About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Inflammation in Methamphetamine and STIs (IMSTI) | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNANCT05162391

Inflammation in Methamphetamine and STIs (IMSTI)

This clinical trial aims to investigate the effects of a decline in methamphetamine use on rectal inflammatory cytokine levels, substance use contexts, and HIV/STI risk behavior. This clinical trial a...

Lead sponsor: University of California, Los Angeles•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of California, Los Angeles

Age

18 - No limit years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Cisgender male
•18 years of age or older
•Understand written and spoken English
•Condomless receptive anal intercourse in past 90 days
•Meet DSM-5 criteria for methamphetamine use disorder
•Positive urine toxicology screen for MA metabolites at study entry
•Negative rectal GC/CT screen (n=20) or Positive rectal GC and/or CT screen (n=20)
•Able to provide written informed consent and willing/able to complete study visits.

Exclusion Criteria

•Reports current treatment for another substance use disorder
•Positive test for opioids, cocaine, and/or hallucinogens
•Treatment for gonorrhea and/or chlamydia infection in past 3 months
•Presence of a condition that in the opinion of the investigator would compromise the safety of the patient or the quality of the data

Related studies

RECRUITINGPhase 3

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

NCT06233799 · Methamphetamine-dependence, Methamphetamine Abuse

Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

NCT04927143 · Opioid-use Disorder, Cocaine Use Disorder, and more

Role of Pavlovian Mechanisms for Control Over Substance Use

NCT06701487 · Alcohol Use Disorder (AUD), Alcoholism, and more

Active Not RecruitingNA

MHealth Incentivized Adherence Plus Patient Navigation

NCT06027814 · Opioid Use Disorder, Medication Adherence, and more

COMPLETEDPhase 2

Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users

NCT03341078 · Methamphetamine-dependence

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 15, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment30

Start dateMay 2022

Last updatedMay 15, 2025

Condition

Methamphetamine-dependence Rectal Gonorrhea Rectal Chlamydia

Locations shown

UCLA Vine Street Clinic

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 15, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions